The global Kidney Function Tests Market was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 1.8 billion by 2033, registering a CAGR of 5.9% from 2026 to 2033. North America accounted for the largest market share with a 36.2% revenue share in 2025, supported by advanced healthcare infrastructure, high awareness of kidney diseases, and strong adoption of diagnostic technologies.

Market growth is primarily driven by increasing investments by industry participants, expanding research and development activities, a rising prevalence of chronic kidney disease (CKD), favorable government initiatives, and continuous technological advancements in renal diagnostics. Growing awareness regarding preventive healthcare and routine kidney health screening is further encouraging the adoption of kidney function tests across hospitals, diagnostic laboratories, and home healthcare settings.

Kidney function tests have become an essential component of modern healthcare as they enable early detection of renal impairment, monitor disease progression, evaluate treatment effectiveness, and support timely clinical intervention. The increasing burden of diabetes, hypertension, cardiovascular diseases, and aging populations worldwide continues to strengthen demand for accurate, rapid, and accessible kidney diagnostics.

Download a free sample copy of the Kidney Function Tests Market report to understand detailed coverage and inclusions in the final report

Rising Burden of Chronic Kidney Disease Accelerating Market Growth

The growing prevalence of acute kidney injury (AKI) and its progression to chronic kidney disease (CKD) remains one of the primary factors driving the kidney function tests market.

CKD is characterized by persistent structural or functional abnormalities of the kidneys lasting at least three months and has become a major global healthcare challenge. Lifestyle-related diseases, diabetes, hypertension, obesity, and kidney injuries continue to significantly contribute to CKD incidence worldwide.

According to the World Health Organization (WHO), kidney disease has become one of the top ten leading causes of death globally over the past decade. In addition, the National Kidney Foundation estimates that approximately 37 million people in the United States, or more than one in seven adults, are living with some form of kidney disease.

The COVID-19 pandemic further highlighted the importance of kidney health, as research demonstrated a significant increase in renal injury among infected patients. Individuals with pre-existing renal diseases experienced higher rates of severe complications and poorer clinical outcomes. Although lockdowns temporarily delayed routine diagnostic testing and disease detection, healthcare systems have resumed preventive screening programs, supporting renewed growth in kidney function testing.

The growing prevalence of diabetes and hypertension continues to be the leading contributor to CKD worldwide. Nearly one-third of diabetic patients develop kidney-related complications due to prolonged hyperglycemia and uncontrolled blood pressure. According to the Centers for Disease Control and Prevention (CDC), the prevalence of diagnosed and undiagnosed diabetes among U.S. adults reached 15.8% as of August 2023, with 4.5% remaining undiagnosed. Furthermore, the International Diabetes Federation (IDF) projects that 783 million adults globally—nearly one in eight people—will be living with diabetes by 2045, representing a 46% increase, with Type 2 diabetes accounting for more than 90% of cases.

Emerging Industry Trend: Digital Kidney Diagnostics and Home-Based Testing

Digital healthcare is transforming renal diagnostics through the growing adoption of home-based kidney function testing and digital urinalysis platforms. Smartphone-enabled diagnostic solutions are improving accessibility, increasing patient compliance, and supporting early disease detection outside traditional healthcare facilities.

For instance, Healthy.io developed an FDA-approved smartphone urinalysis solution capable of detecting proteinuria using disposable test strips and smartphone imaging technology. Its Dip.io platform demonstrated a 71% patient adherence rate during clinical trials conducted with Geisinger Health and the National Kidney Foundation, highlighting the growing potential of digital diagnostics in preventive kidney care.

Technological Advancements Enhancing Renal Diagnostics

Technological innovation continues to improve the speed, accuracy, and accessibility of kidney function testing.

Major advancements include:

• AI-powered kidney disease risk assessment
• Blood biomarker-based renal diagnostics
• Smartphone-enabled digital urinalysis
• Home-based kidney evaluation kits
• Point-of-care renal testing devices
• Automated laboratory analyzers
• Cystatin C-based kidney assessment
• Machine learning-enabled clinical decision support

These innovations enable healthcare providers to detect kidney disease earlier, improve patient monitoring, reduce diagnostic delays, and support personalized treatment strategies.

Looking for more specific insights? Customize this report to suite your business needs

Key Market Trends & Insights

Clearance Tests Continue to Lead Product Segment

• By product, the clearance tests segment held the largest market share of 27.5% in 2025.
• Clearance tests, including creatinine and inulin testing, remain the gold standard for evaluating glomerular filtration rate (GFR) because of their high diagnostic accuracy and reliability.
• Their affordability, broad clinical acceptance, and widespread availability continue to drive adoption across healthcare settings.

Hospitals Remain the Largest End-use Segment

• By end use, the hospitals segment accounted for the largest market share of 39.5% in 2025.
• Hospitals perform the highest volume of kidney function tests through integrated diagnostic laboratories and multidisciplinary clinical departments.
• Continuous improvements in healthcare infrastructure, expansion of hospital diagnostic services, and increasing access to advanced laboratory technologies are expected to further support market growth.

Regional Highlights

• Largest Regional Market: North America (36.2% revenue share, 2025)
• Leading Country: United States

North America continues to dominate the kidney function tests market due to strong healthcare infrastructure, increasing chronic disease prevalence, favorable reimbursement policies, extensive preventive screening programs, and the presence of major diagnostic manufacturers.

Market Size & Forecast

• Market Size (2025): USD 1.1 Billion
• Estimated Market Size (2026): USD 1.2 Billion
• Projected Market Size (2033): USD 1.8 Billion
• CAGR (2026–2033): 5.9%

Market growth is further supported by increasing investments in innovative renal diagnostics. In February 2024, Simple HealthKit introduced a renal evaluation test designed for individuals with diabetes that can be used in both clinical and home settings. Additionally, research initiatives such as KidneyX, a collaboration between the U.S. Department of Health and Human Services and the American Society of Nephrology, are accelerating innovation in kidney disease diagnosis, treatment, and prevention. Similarly, Canada's Can-SOLVE Chronic Kidney Disease Network received USD 11.8 million in funding to continue advancing kidney disease research through 2027.

Recent Launches and Technological Advancements

Continuous innovation is strengthening the future of kidney diagnostics.

• In October 2025, Roche introduced the CE-marked AI-based Kidney KlinRisk Algorithm, enabling earlier identification of patients at risk of kidney function decline before formal CKD diagnosis.
• In September 2025, Renalytix, together with Tempus AI, expanded access to KidneyIntelX.dkd, an FDA-approved AI-powered blood test capable of predicting diabetic kidney disease progression years before clinical symptoms appear.
• In August 2022, Bloom Diagnostics launched the Bloom Kidney Test, utilizing cystatin C measurement to evaluate glomerular filtration rate (GFR) and classify kidney function into normal, mildly decreased, and decreased categories.

These innovations are expected to significantly improve diagnostic accuracy, support preventive nephrology, and expand access to early kidney disease detection.

Explore Grand View Horizon to see global and regional level statistics related to the Kidney Function Tests Market

Competitive Landscape

Leading companies operating in the kidney function tests market are focusing on strategic partnerships, product innovation, geographical expansion, AI-enabled diagnostics, and advanced biomarker development to strengthen their global market positions.

Key strategic priorities include:

• AI-driven kidney disease prediction
• Digital renal diagnostics
• Home-based testing solutions
• Advanced biomarker development
• Clinical research collaborations
• Expansion of diagnostic portfolios

Key Kidney Function Tests Companies

The following companies are among the leading participants operating in the global kidney function tests market:

• Abbott
• Danaher
• F. Hoffmann-La Roche Ltd.
• Sysmex Corporation
• Siemens Healthineers
• Randox Laboratories Ltd.
• Quest Diagnostics
• ACON Laboratories, Inc.
• Nova Biomedical Corporation
• Laboratory Corporation of America Holdings

Conclusion

The kidney function tests market is expected to witness steady expansion as the global burden of chronic kidney disease, diabetes, hypertension, and aging populations continues to increase. Growing adoption of AI-powered diagnostics, digital urinalysis, blood biomarker testing, and home-based renal monitoring solutions is reshaping kidney disease detection and management. Continued investments in research, predictive analytics, precision diagnostics, and decentralized healthcare will improve early diagnosis, enhance patient outcomes, and expand access to kidney health services. Companies investing in innovative renal diagnostic technologies and preventive healthcare solutions are expected to strengthen their competitive position in the evolving global kidney function tests market.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments
• Extended forecast timelines for long-term planning
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…